ERIC SHOUP: Open Payments
NPI 1073576781 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,360 in 131 payments from 21 companies in 2025. Trend: 2023 $19,314 · 2024 $10,005 · 2025 $7,360
Speaker / faculty: $3,488Food & beverage: $2,462Travel & lodging: $1,411
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 16 | $5,111 |
| Novartis Pharmaceuticals Corporation | 18 | $364 |
| E.R. Squibb & Sons, L.L.C. | 18 | $217 |
| Philips North America LLC | 8 | $202 |
| Alnylam Pharmaceuticals Inc. | 11 | $196 |
| AstraZeneca Pharmaceuticals LP | 11 | $190 |
| Boston Scientific Corporation | 10 | $162 |
| PFIZER INC. | 7 | $156 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $125 |
| Novo Nordisk Inc | 4 | $110 |
Products named: REPATHA, LEQVIO, ONPATTRO, CAMZYOS, Event, FARXIGA, VYNDAQEL, LifeVest.
Industry payments across SC — which companies pay providers there.
